STRS Ohio’s Insys Therapeutics, Inc. INSY Stock Holding History

STRS Ohio’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,200	Closed	-$11K	–	2138
2018 Q4	$11K	Hold	3,200	–	–	﹤0.01%	2026
2018 Q3	$32K	Buy	+3,200	New	+$25.5K	﹤0.01%	1997
2017 Q4	–	Sell	-175,000	Closed	-$1.55M	–	1971
2017 Q3	$1.55M	Hold	175,000	–	–	0.01%	690
2017 Q2	$2.21M	Buy	175,000 +50,000	+40%	+$592K	0.01%	611
2017 Q1	$1.31M	Hold	125,000	–	–	0.01%	723
2016 Q4	$1.15M	Hold	125,000	–	–	0.01%	780
2016 Q3	$1.47M	Hold	125,000	–	–	0.01%	680
2016 Q2	$1.62M	Hold	125,000	–	–	0.01%	652
2016 Q1	$2M	Sell	125,000 -305,000	-71%	-$5.79M	0.01%	616
2015 Q4	$12.3M	Sell	430,000 -71,600	-14%	-$1.98M	0.06%	346
2015 Q3	$14.3M	Buy	501,600 +164,900	+49%	+$6.07M	0.07%	328
2015 Q2	$12.1M	Sell	336,700 -79,900	-19%	-$2.49M	0.05%	366
2015 Q1	$12.1M	Buy	+416,600	New	+$11M	0.05%	361
2014 Q2	–	Sell	-27,800	Closed	-$576K	–	1808
2014 Q1	$576K	Sell	27,800 -24,100	-46%	-$478K	﹤0.01%	1102
2013 Q4	$670K	Buy	51,900 +21,000	+68%	+$291K	﹤0.01%	1063
2013 Q3	$360K	Buy	30,900 +23,700	+329%	+$195K	﹤0.01%	1314
2013 Q2	$33K	Buy	+7,200	New	+$26.4K	﹤0.01%	1774

Other funds holding INSY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

STRS Ohio's INSY Position: Q1 2019 in Review

STRS Ohio sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 3,200 shares — an estimated $11K sold.

STRS Ohio first reported a position in INSY in Q2 2013 and held it in 17 quarters. The position peaked at $14.3M in Q3 2015. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

STRS Ohio reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
STRS Ohio sold 3,200 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $11K.
STRS Ohio first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 17 quarters.
STRS Ohio's Insys Therapeutics, Inc. position peaked at $14.3M in Q3 2015.
98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on STRS Ohio's 13F filing for Q1 2019, filed 19 Apr 2019.